Damien Duval
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Damien Duval has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Jean Merot
Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du thorax , F-44000 Nantes , France
4 shared publications - Jean-Jacques Schott
Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du thorax , F-44000 Nantes
4 shared publications - Thierry Le Tourneau
Nantes Université, CHU Nantes, CNRS, INSERM, l’institut du Thorax, Nantes, France
4 shared publications - Vincent Probst
CHU Nantes, L’institut Du Thorax, Nantes, France
3 shared publications Antoine Rimbert
2 shared publicationsFlorence Kyndt
2 shared publications
Latest Publications
- Open Access
- 8 September 2015
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 2 (3) , 233-247
MVP-Associated Filamin A Mutations Affect FlnA-PTPN12 (PTP-PEST) Interactions
Although the genetic basis of mitral valve prolapse (MVP) has now been clearly established, the molecular and cellular mechanisms involved in the pathological processes associated to a specific mutation often remain to be determined. The FLNA gene (encoding Filamin A; FlnA) was the first gene associated to non-syndromic X-linked myxomatous valvular dystrophy, but the impacts of the mutations on its function remain un-elucidated. Here, using the first repeats (1–8) of FlnA as a bait in a yeast two-hybrid screen, we identified the tyrosine phosphatase PTPN12 (PTP-PEST) as a specific binding partner of this region of FlnA protein. In addition, using yeast two-hybrid trap assay pull down and co-immunoprecipitation experiments, we showed that the MVP-associated FlnA mutations (G288R, P637Q, H743P) abolished FlnA/PTPN12 interactions. PTPN12 is a key regulator of signaling pathways involved in cell-extracellular matrix (ECM) crosstalk, cellular responses to mechanical stress that involve integrins, focal adhesion transduction pathways, and actin cytoskeleton dynamics. Interestingly, we showed that the FlnA mutations impair the activation status of two PTPN12 substrates, the focal adhesion associated kinase Src, and the RhoA specific activating protein p190RhoGAP. Together, these data point to PTPN12/FlnA interaction and its weakening by FlnA mutations as a mechanism potentially involved in the physiopathology of FlnA-associated MVP.
- 8 September 2015
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 2 (3) , 233-247
Open AccessMVP-Associated Filamin A Mutations Affect FlnA-PTPN12 (PTP-PEST) Interactions
Although the genetic basis of mitral valve prolapse (MVP) has now been clearly established, the molecular and cellular mechanisms involved in the pathological processes associated to a specific mutation often remain to be determined. The FLNA gene (encoding Filamin A; FlnA) was the first gene associated to non-syndromic X-linked myxomatous valvular dystrophy, but the impacts of the mutations on its function remain un-elucidated. Here, using the first repeats (1–8) of FlnA as a bait in a yeast two-hybrid screen, we identified the tyrosine phosphatase PTPN12 (PTP-PEST) as a specific binding partner of this region of FlnA protein. In addition, using yeast two-hybrid trap assay pull down and co-immunoprecipitation experiments, we showed that the MVP-associated FlnA mutations (G288R, P637Q, H743P) abolished FlnA/PTPN12 interactions. PTPN12 is a key regulator of signaling pathways involved in cell-extracellular matrix (ECM) crosstalk, cellular responses to mechanical stress that involve integrins, focal adhesion transduction pathways, and actin cytoskeleton dynamics. Interestingly, we showed that the FlnA mutations impair the activation status of two PTPN12 substrates, the focal adhesion associated kinase Src, and the RhoA specific activating protein p190RhoGAP. Together, these data point to PTPN12/FlnA interaction and its weakening by FlnA mutations as a mechanism potentially involved in the physiopathology of FlnA-associated MVP.
- 1 January 2015
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 7 (1) , 51
0493: Mutations in the gene encoding FilGAP as a cause for mitral valve prolapse
- 1 January 2015
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 7 (1) , 51
0493: Mutations in the gene encoding FilGAP as a cause for mitral valve prolapse
- 1 April 2014
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 6, 72-73
0030: ARHGAP 24/ (FilGAP); a new gene responsible for mitral valve prolapse
- 1 April 2014
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 6, 72-73
0030: ARHGAP 24/ (FilGAP); a new gene responsible for mitral valve prolapse
- 4 November 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1843 (2) , 234-244
Valvular dystrophy associated filamin A mutations reveal a new role of its first repeats in small-GTPase regulation
- 4 November 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1843 (2) , 234-244
Valvular dystrophy associated filamin A mutations reveal a new role of its first repeats in small-GTPase regulation